Longs investors question deal
- Share via
Some Longs Drug Stores Corp. shareholders said they would oppose CVS Caremark Corp.’s $2.7-billion offer to buy the company if Longs didn’t tell them more about the value of its real estate.
CVS Caremark agreed to pay $71.50 a share for Longs to gain more than 500 stores. CVS valued Longs’ real estate at about $1 billion. But CtW Investment Group said the price was too low by as much as $260 million, and two major Longs shareholders said they wanted to know more about how the real estate was valued.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
